| 000 | 01367 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515154019.0 | ||
| 264 | 0 | _c20090427 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a0091-3057 | ||
| 024 | 7 |
_a10.1016/j.pbb.2008.12.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuhad, Anurag | |
| 245 | 0 | 0 |
_aSuppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. _h[electronic resource] |
| 260 |
_bPharmacology, biochemistry, and behavior _cApr 2009 |
||
| 300 |
_a251-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aCognition Disorders _xcomplications |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aStreptozocin |
| 650 | 0 | 4 |
_aTocotrienols _xpharmacology |
| 700 | 1 | _aBishnoi, Mahendra | |
| 700 | 1 | _aTiwari, Vinod | |
| 700 | 1 | _aChopra, Kanwaljit | |
| 773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 92 _gno. 2 _gp. 251-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pbb.2008.12.012 _zAvailable from publisher's website |
| 999 |
_c18586836 _d18586836 |
||